The University of Southampton
University of Southampton Institutional Repository

Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials

Smith, Lesley A., Cornelius, Victoria, Warnock, Adrian, Tacchi, Mary Jane and Taylor, David (2007) Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials Bipolar Disorders, 9, (6), pp. 551-560. (doi:10.1111/j.1399-5618.2007.00468.x).

Record type: Article


Objectives: We conducted a systematic review and meta-analysis of randomized, placebo-controlled trials in acute bipolar mania to summarize available data on drug treatment of mania.

Methods: We included trials of medications licensed in the USA or UK for the treatment of any phase of bipolar disorder. Outcomes investigated were changes in mania scores, attrition, extrapyramidal effects and weight change. Data were combined through meta-analyses.

Results: We included 13 studies (involving 3,089 subjects) and identified 2 studies for each of the following medications: carbamazepine, haloperidol, lithium, olanzapine, quetiapine, risperidone, valproate semisodium and aripiprazole. All drugs showed significant benefit compared with placebo for reduction in mania scores. Compared with placebo, for all antipsychotics pooled, response to treatment (?50% reduction in Young Mania Rating Scale scores) was increased more than 1.7 times [relative risk (RR) = 1.74, 95% confidence interval (CI) = 1.54, 1.96]; for all mood stabilizers pooled, response to treatment was doubled (RR 2.01, 95% CI = 1.66, 2.43). Overall withdrawals were 34% fewer (24–43%) with antipsychotics, and 26% fewer (10–39%) with mood stabilizers. However, for carbamazepine, aripiprazole and lithium an increase in risk of withdrawal could not be excluded. Small but significant increases in extrapyramidal side effects occurred with risperidone and aripiprazole.

Conclusions: Antipsychotics and mood stabilizers are significantly more effective than placebo for the treatment of acute mania. Their effect sizes are similar. Small differences between effect sizes may be due to differences in the patients included in the studies or to chance. Carbamazepine and lithium may be more poorly tolerated, and antipsychotics cause more extrapyramidal side effects.

Full text not available from this repository.

More information

Published date: September 2007
Keywords: antipsychotics, mania, meta-analysis, mood stabilizers, randomized controlled study


Local EPrints ID: 162293
ISSN: 1398-5647
PURE UUID: 8c1fbeb1-e73a-4726-aab0-e4e216f882ca

Catalogue record

Date deposited: 18 Aug 2010 09:20
Last modified: 18 Jul 2017 12:32

Export record



Author: Lesley A. Smith
Author: Victoria Cornelius
Author: Adrian Warnock
Author: Mary Jane Tacchi
Author: David Taylor

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.